Drug Shows Promise in Preventing EHV-1 Neurological Complication
by EQUUS magazine, US Equestrian Media Partner | October 3, 2017
This article originally was published in the May 2017 issue of EQUUS magazine, a media partner of US Equestrian. Low doses of a common anticoagulant drug may help prevent a life-threatening neurological complication of equine herpesvirus type 1 (EHV-1) infection. Typically, EHV-1 causes only mild clinical signs, but in outbreak situations, an estimated 33 percent of infected horses may develop equine herpesvirus myeloencephalopathy (EHM), which is characterized by damage of the blood












